Cyclic gmp-specific phosphodiesterase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/14 (2006.01) A61K 31/495 (2006.01)

Patent

CA 2226761

A compound of formula (I) and solvates thereof, in which R0 represents hydrogen, halogen or C1-6alkyl; R1 represents hydrogen or C1-6alkyl; R2 represents the bicyclic ring (1) which may be optionally substituted by one or more groups selected from halogen and C1-3alkyl; and R3 represents hydrogen or C1-3alkyl. A compound of the present invention is a potent and selective inhibitor of cGMP specific PDE having a utility in a variety of therapeutic areas where such inhibition is beneficial.

Composé de formule (I) et ses solvates, dans laquelle R?0¿ représente hydrogène, halogène ou alkyle en C¿1-6?; R?1¿ représente hydrogène ou alkyle en C¿1-6?; R?2¿ représente le noyau bicyclique (1) pouvant être éventuellement substitué par un ou plusieurs groupes choisis entre halogène et alkyle en C¿1-3?; et R?3¿ représente hydrogène ou alkyle en C¿1-3?. Un composé de la présente invention constitue un inhibiteur puissant et sélectif de PDE spécifique de GMP cyclique présentant une utilité dans divers domaines thérapeutiques dans lesquels une telle inhibition est avantageuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic gmp-specific phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic gmp-specific phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic gmp-specific phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1618014

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.